Expert insights. Personalized for you.
Cannabis Featured Medical Marijuana News Politics DEA fentanyl opioid crisis white houseWhy Is The White House Lying About Marijuana And Fentanyl? MORE
We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. It’s been nearly three years since the DEA announced its revolutionary cultivator program. MORE
The post CVS Ignores DEA, Says It’s Already Selling CBD Products appeared first on Leafly. Industry Politics cannabidiol cbd DEA FDAThe nation's largest drugstore chain is selling CBD products in 8 states. Meanwhile, independent CBD stores are being raided by police in Texas. MORE
MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MORE
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim. MORE
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim. MORE
DEA Chief of Operations D. DEA Chief of Operations D. Christopher Evans is an outstanding selection for the Presidential Law Enforcement Commission,” said DEA Acting Administrator Uttam Dhillon. “As DEA Chief of Operations D. MORE
Domestic Hemp Production Program must be registered with the Drug Enforcement Administration (DEA) to handle controlled substances. The directory below summarizes hemp testing laboratories who are registered with the DEA. Any laboratory testing hemp for THC concentration under the U.S. MORE
The U.S. Food and Drug Administration and the Drug Enforcement Administration seized forty-four websites offering to sell illicit vaping cartridges containing tetrahydrocannabinol (THC), the primary psychoactive component of the cannabis plant. MORE
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim. MORE
The Drug Enforcement Administration (DEA) finalized its plans to authorize the cultivation of 3,200,000 grams of marijuana for research purposes next year—a 30 percent increase from 2019’s quota. DEA Finalizes Plan To Grow 3.2 MORE
Circuit Court of Appeals that the DEA’s refusal to reschedule cannabis damaged their health and that the federal agency should remove cannabis from Schedule 1. Federal appeals court to DEA: Reconsider marijuana’s Schedule 1 status. MORE
A federal court dismissed a lawsuit against the Drug Enforcement Administration (DEA) on Friday after determining that the agency had fulfilled a requirement to process applications for research-grade marijuana manufacturers. Marijuana Moment reports. MORE
Defendants are acting-Attorney General Matthew Whitaker, the acting director of the DEA and the federal government. Additional Resources: Appeal Hearing in Cannabis Lawsuit Against the DEA , Dec. A federal lawsuit against the U.S. Drug Enforcement Administration and the U.S. MORE
Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications. MORE
As a Marine Corps federal prosecutor, DEA Drug Task Force Commander and state narcotics prosecutor, Charles spent many years engaged in the War on Drugs. A Former DEA Prosecutor’s Journey into the Global Cannabis Industry. MORE
DEA Announces Steps Necessary to Improve Access to Marijuana Research. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. Following. The Press Release in full. Department of Justice. MORE
Military.com reports. During a hearing Tuesday on eight VA health-related bills under consideration by Congress, VA officials told House lawmakers that as long as marijuana is illegal under federal law, the department cannot support legislation that promotes its role at the VA. MORE
Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. DEA, the DEA expressed in their brief that they do not wish to control cannabinoids, but rather only those cannabinoids derived from the flowers and resins of a cannabis plant above.3% On Monday, the U.S. MORE
The Marijuana Time introduce their article by writing… A cannabis researcher at Arizona’s Scottsdale Research Institute plans to sue the Drug Enforcement Administration (DEA) over what she is saying is low-grade cannabis that is unacceptable for testing. MORE
” Last year, however, former DEA director Robert Patterson testified to Congress that the agency believed that approving additional applicants would likely violate international anti-drug treaties. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue. ” Although that ruling ordered DEA to lift the ban, the agency failed to do so. MORE
” To date, however, the agency has neither affirmed or denied any of the 26 applicants that have sought the DEA’s permission for a federal cultivation license. “[This filing is] asking the court for an order compelling the DEA to process our application. MORE
The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action. MORE
DEA Role. DEA will continue to have a role in the hemp program. The regulation requires that testing be done by a DEA registered lab and that in the disposal of hemp above 0.3% must be accomplished under DEA guidance. All lab results are shared information with USDA, which will share information with DEA. Blog Cannabis Cannabis Blog Federal Hemp and CBD Legal Updates Publications DEA famr bill hemp hemp program THC testing usda MORE
The report reveals … ndustry members worry the limitation could delay THC testing and create bottlenecks, especially in remote areas far from a DEA-registered lab. “It This is a departure for the DEA, which does not require labs to be accredited to handle narcotics. MORE
The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —. MORE
On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. The post The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval? MORE
The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA. Like a child who does not want to clean his or her room, the DEA simply refuses to take any major action, despite the whirlwind of reforms surrounding them on a daily basis. The court’s sense of urgency finally puts judicial pressure on the DEA. The DEA is now forced to face the issue. MORE
Domestic Hemp Production Program must be registered with the Drug Enforcement Administration (DEA) to handle controlled substances. The directory below summarizes hemp testing laboratories who are registered with the DEA. Any laboratory testing hemp for THC concentration under the U.S. MORE
Two days before a federal court deadline, the DEA says it will do what it said it would do three years ago. The post DEA Says It Will Finally Let Others Grow Research-Grade Cannabis appeared first on Leafly. Politics DEA research MORE
Cannabis Medical Marijuana News RX DEA eyedrops FDA Glaucoma stoners THC topicalsGlaucoma And Medical Marijuana: 5 Informative Facts Medical marijuana glaucoma treatment can help reduced eye pressure and relieve pain. Here's what you need to know about using cannabis for eye health. The post Glaucoma And Medical Marijuana: 5 Informative Facts appeared first on The Fresh Toast. MORE
Cannabis Medical Marijuana News DEA marijuana research NIDAThe National Institute of Drug Abuse announced plans to grow the largest crop of research marijuana in five years. Continue reading Is The Federal Government Finally Serious About Marijuana Research? at The Fresh Toast. MORE
Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. Here, DEA can act with little expenditure of resources.”. MORE
We have noted previously that the federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1% cannabidiol cbd dea Drug Enforcement Agency tetrahydrocannabinols THCThe Western District of New York, in Horn v. MORE
Cannabis Medical Marijuana News RX DEA eyedrops FDA Glaucoma stoners THC topicalsGlaucoma And Medical Marijuana: 5 Informative Facts Medical marijuana glaucoma treatment can help reduced eye pressure and relieve pain. Here's what you need to know about using cannabis for eye health. MORE
You might think it’s California,but actually it is …… According to recently published DEA data about illegal grows it is Kentucky, where both recreational and medical marijuana are still illegal. The DEA confiscated over 1.8 MORE
According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report, the agency and its law enforcement partners confiscated an estimated 2.82 LAW ENFORCEMENT assets DEA eradication legalization seizures MORE
Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. The DEA has routinely denied each petition, or declined to accept it outright. MORE
Separate data reported by the US Drug Enforcement Administration in July reported a decline in DEA-led marijuana seizures, but showed an increase in DEA arrests for marijuana violations in 2018. MORE
The DEA is proposing an increase in the amount of cannabis that can be grown for research purposes. Science MORE
The DEA is moving to offer proposed regulations for researchers who want to grow cannabis; the regulations are currently under review by the Office of Management and Budget. Week in Weed dea decriminalization florida hearings hemp house energy and commerce committee michigan mississippi omb research south dakota tennesseeWelcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. MORE
Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. This likely would have been longer, but the DEA had not anticipated a legal threat to force some action. MORE
How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate? With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered. MORE
The post Wasn’t the DEA Going to Let Others Grow Research-Grade Cannabis? Science & Tech DEA nida researchYes, it was. So why has the agency delayed applications? Sue Sisley demands an answer, and the courts agree with her. MORE
DEA Related Topics 
NORML
JULY 16, 2019
According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report, the agency and its law enforcement partners confiscated an estimated 2.82 LAW ENFORCEMENT assets DEA eradication legalization seizures
NORML
AUGUST 26, 2019
The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
SEPTEMBER 20, 2019
We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. It’s been nearly three years since the DEA announced its revolutionary cultivator program.
NORML
OCTOBER 21, 2019
Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications.
NORML
AUGUST 2, 2019
” To date, however, the agency has neither affirmed or denied any of the 26 applicants that have sought the DEA’s permission for a federal cultivation license. “[This filing is] asking the court for an order compelling the DEA to process our application.
Leafly
AUGUST 26, 2019
Two days before a federal court deadline, the DEA says it will do what it said it would do three years ago. The post DEA Says It Will Finally Let Others Grow Research-Grade Cannabis appeared first on Leafly. Politics DEA research
Leafly
AUGUST 19, 2019
The post Wasn’t the DEA Going to Let Others Grow Research-Grade Cannabis? Science & Tech DEA nida researchYes, it was. So why has the agency delayed applications? Sue Sisley demands an answer, and the courts agree with her.
|
Leafly
MARCH 22, 2019
The post CVS Ignores DEA, Says It’s Already Selling CBD Products appeared first on Leafly. Industry Politics cannabidiol cbd DEA FDAThe nation's largest drugstore chain is selling CBD products in 8 states. Meanwhile, independent CBD stores are being raided by police in Texas.
WeedAdvisor
AUGUST 28, 2019
Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. This likely would have been longer, but the DEA had not anticipated a legal threat to force some action.
Cannabis Law Report
DECEMBER 2, 2019
The Drug Enforcement Administration (DEA) finalized its plans to authorize the cultivation of 3,200,000 grams of marijuana for research purposes next year—a 30 percent increase from 2019’s quota. DEA Finalizes Plan To Grow 3.2
CannaTech
JUNE 23, 2019
As a Marine Corps federal prosecutor, DEA Drug Task Force Commander and state narcotics prosecutor, Charles spent many years engaged in the War on Drugs. A Former DEA Prosecutor’s Journey into the Global Cannabis Industry.
Cannabis Law Report
AUGUST 24, 2019
The Marijuana Time introduce their article by writing… A cannabis researcher at Arizona’s Scottsdale Research Institute plans to sue the Drug Enforcement Administration (DEA) over what she is saying is low-grade cannabis that is unacceptable for testing.
Cannabis Law Report
SEPTEMBER 9, 2019
The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.
|
|
WeedAdvisor
JUNE 1, 2019
The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA. Like a child who does not want to clean his or her room, the DEA simply refuses to take any major action, despite the whirlwind of reforms surrounding them on a daily basis. The court’s sense of urgency finally puts judicial pressure on the DEA. The DEA is now forced to face the issue.
Cannabis Law Report
DECEMBER 23, 2019
The U.S. Food and Drug Administration and the Drug Enforcement Administration seized forty-four websites offering to sell illicit vaping cartridges containing tetrahydrocannabinol (THC), the primary psychoactive component of the cannabis plant.
Cannabis Law Report
NOVEMBER 20, 2019
The report reveals … ndustry members worry the limitation could delay THC testing and create bottlenecks, especially in remote areas far from a DEA-registered lab. “It This is a departure for the DEA, which does not require labs to be accredited to handle narcotics.
Cannabis Law Report
AUGUST 26, 2019
DEA Announces Steps Necessary to Improve Access to Marijuana Research. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. Following. The Press Release in full. Department of Justice.
Cannabis Law Report
NOVEMBER 11, 2019
You might think it’s California,but actually it is …… According to recently published DEA data about illegal grows it is Kentucky, where both recreational and medical marijuana are still illegal. The DEA confiscated over 1.8
Canna Law Blog
JUNE 1, 2019
Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. The DEA has routinely denied each petition, or declined to accept it outright.
Cannabis Law Report
JANUARY 22, 2020
DEA Chief of Operations D. DEA Chief of Operations D. Christopher Evans is an outstanding selection for the Presidential Law Enforcement Commission,” said DEA Acting Administrator Uttam Dhillon. “As DEA Chief of Operations D.
Cannabis Law Report
JUNE 3, 2019
Circuit Court of Appeals that the DEA’s refusal to reschedule cannabis damaged their health and that the federal agency should remove cannabis from Schedule 1. Federal appeals court to DEA: Reconsider marijuana’s Schedule 1 status.
Cannabis Law Report
NOVEMBER 22, 2019
MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada.
Cannabis Law Report
OCTOBER 21, 2019
A federal court dismissed a lawsuit against the Drug Enforcement Administration (DEA) on Friday after determining that the agency had fulfilled a requirement to process applications for research-grade marijuana manufacturers. Marijuana Moment reports.
Freedom Leaf
OCTOBER 15, 2018
On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. The post The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?
Marijuana Lawyer Blog
JANUARY 12, 2019
Defendants are acting-Attorney General Matthew Whitaker, the acting director of the DEA and the federal government. Additional Resources: Appeal Hearing in Cannabis Lawsuit Against the DEA , Dec. A federal lawsuit against the U.S. Drug Enforcement Administration and the U.S.
MJ Business Attorneys
JUNE 29, 2018
Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. DEA, the DEA expressed in their brief that they do not wish to control cannabinoids, but rather only those cannabinoids derived from the flowers and resins of a cannabis plant above.3% On Monday, the U.S.
NORML
MARCH 1, 2019
” Last year, however, former DEA director Robert Patterson testified to Congress that the agency believed that approving additional applicants would likely violate international anti-drug treaties. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue. ” Although that ruling ordered DEA to lift the ban, the agency failed to do so.
The Fresh Toast
APRIL 2, 2019
Cannabis Medical Marijuana News RX DEA eyedrops FDA Glaucoma stoners THC topicalsGlaucoma And Medical Marijuana: 5 Informative Facts Medical marijuana glaucoma treatment can help reduced eye pressure and relieve pain. Here's what you need to know about using cannabis for eye health.
The Fresh Toast
MARCH 28, 2019
Cannabis Featured Medical Marijuana News Politics DEA fentanyl opioid crisis white houseWhy Is The White House Lying About Marijuana And Fentanyl?
Cannabis Maven
SEPTEMBER 12, 2019
The DEA is proposing an increase in the amount of cannabis that can be grown for research purposes. Science
The Blunt Truth
OCTOBER 15, 2019
We have noted previously that the federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1% cannabidiol cbd dea Drug Enforcement Agency tetrahydrocannabinols THCThe Western District of New York, in Horn v.
The Blunt Truth
JANUARY 16, 2020
The DEA is moving to offer proposed regulations for researchers who want to grow cannabis; the regulations are currently under review by the Office of Management and Budget. Week in Weed dea decriminalization florida hearings hemp house energy and commerce committee michigan mississippi omb research south dakota tennesseeWelcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.
NORML
JANUARY 16, 2020
Separate data reported by the US Drug Enforcement Administration in July reported a decline in DEA-led marijuana seizures, but showed an increase in DEA arrests for marijuana violations in 2018.
Greenspoon Marder Cannabis Law Group Blog
OCTOBER 30, 2019
DEA Role. DEA will continue to have a role in the hemp program. The regulation requires that testing be done by a DEA registered lab and that in the disposal of hemp above 0.3% must be accomplished under DEA guidance. All lab results are shared information with USDA, which will share information with DEA. Blog Cannabis Cannabis Blog Federal Hemp and CBD Legal Updates Publications DEA famr bill hemp hemp program THC testing usda
The Fresh Toast
APRIL 2, 2019
Cannabis Medical Marijuana News RX DEA eyedrops FDA Glaucoma stoners THC topicalsGlaucoma And Medical Marijuana: 5 Informative Facts Medical marijuana glaucoma treatment can help reduced eye pressure and relieve pain. Here's what you need to know about using cannabis for eye health. The post Glaucoma And Medical Marijuana: 5 Informative Facts appeared first on The Fresh Toast.
The Fresh Toast
JULY 15, 2019
Cannabis Medical Marijuana News DEA marijuana research NIDAThe National Institute of Drug Abuse announced plans to grow the largest crop of research marijuana in five years. Continue reading Is The Federal Government Finally Serious About Marijuana Research? at The Fresh Toast.
Cannabis Law Report
MAY 2, 2019
Military.com reports. During a hearing Tuesday on eight VA health-related bills under consideration by Congress, VA officials told House lawmakers that as long as marijuana is illegal under federal law, the department cannot support legislation that promotes its role at the VA.
United Patients Group
AUGUST 21, 2017
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim.
Cannabis Law Report
JANUARY 16, 2020
Domestic Hemp Production Program must be registered with the Drug Enforcement Administration (DEA) to handle controlled substances. The directory below summarizes hemp testing laboratories who are registered with the DEA. Any laboratory testing hemp for THC concentration under the U.S.
Project CBD
JULY 31, 2018
How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate? With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered.
Cannabis Law Report
DECEMBER 15, 2019
Domestic Hemp Production Program must be registered with the Drug Enforcement Administration (DEA) to handle controlled substances. The directory below summarizes hemp testing laboratories who are registered with the DEA. Any laboratory testing hemp for THC concentration under the U.S.
United Patients Group
AUGUST 21, 2017
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim.
United Patients Group
AUGUST 21, 2017
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim.
91 
Let's personalize your content